rs41291957
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000602315.3(CARMN):n.657-56G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.125 in 457,350 control chromosomes in the GnomAD database, including 4,704 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1556 hom., cov: 32)
Exomes 𝑓: 0.13 ( 3148 hom. )
Consequence
CARMN
ENST00000602315.3 intron
ENST00000602315.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0550
Publications
31 publications found
Genes affected
CARMN (HGNC:42872): (cardiac mesoderm enhancer-associated non-coding RNA) Predicted to be involved in regulation of gene expression. [provided by Alliance of Genome Resources, Apr 2022]
MIR143 (HGNC:31530): (microRNA 143) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18146AN: 152108Hom.: 1556 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18146
AN:
152108
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.128 AC: 39185AN: 305122Hom.: 3148 Cov.: 0 AF XY: 0.123 AC XY: 21202AN XY: 172984 show subpopulations
GnomAD4 exome
AF:
AC:
39185
AN:
305122
Hom.:
Cov.:
0
AF XY:
AC XY:
21202
AN XY:
172984
show subpopulations
African (AFR)
AF:
AC:
230
AN:
8422
American (AMR)
AF:
AC:
2278
AN:
26322
Ashkenazi Jewish (ASJ)
AF:
AC:
838
AN:
10300
East Asian (EAS)
AF:
AC:
2776
AN:
9008
South Asian (SAS)
AF:
AC:
3712
AN:
59080
European-Finnish (FIN)
AF:
AC:
5402
AN:
21254
Middle Eastern (MID)
AF:
AC:
79
AN:
1440
European-Non Finnish (NFE)
AF:
AC:
22080
AN:
155496
Other (OTH)
AF:
AC:
1790
AN:
13800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1622
3244
4865
6487
8109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.119 AC: 18155AN: 152228Hom.: 1556 Cov.: 32 AF XY: 0.126 AC XY: 9349AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
18155
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
9349
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
1202
AN:
41556
American (AMR)
AF:
AC:
1354
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
293
AN:
3468
East Asian (EAS)
AF:
AC:
1602
AN:
5166
South Asian (SAS)
AF:
AC:
332
AN:
4828
European-Finnish (FIN)
AF:
AC:
2844
AN:
10584
Middle Eastern (MID)
AF:
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10005
AN:
68004
Other (OTH)
AF:
AC:
216
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
762
1524
2286
3048
3810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
664
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.